Breast Cancer Self-Efficacy Scale for Partners

NCT05228210 | Terminated

• 1 other identifier: 1905795920
• Study Type: observational
• Target: 25
• Locations: 1 country
• Sites: 1

Brief Summary

The concept of self-efficacy is a major predictor of physical, psychological, social and overall quality of life (QoL) among breast cancer survivors (BCS). Because survivor and partner outcomes are often linked, it is reasonable to hypothesize that self-efficacy is an important predictor of physical, psychological, social and overall QoL in partners as well. However, this hypothesis has yet to be tested, in part because no scale exists to measure cancer-related self-efficacy in partners. Development and psychometric testing of such a scale is a critical first step in developing a theoretical model predicting QoL in this population. Partners of BCS often report lower QoL compared to partners of healthy women, making them an important focus of research. During the award period, the applicant will follow standard instrument development procedures to develop the Breast Cancer Self-Efficacy Scale for Partners (BCSES-P) and test the scale's psychometric properties using a large and diverse sample of partners of breast cancer survivors.

Conditions

Breast Cancer

Outcome Measures

Primary Outcomes (1)

• Fear of Cancer Progression and Recurrence (FCR7)

  7-item scale assessing concerns that the cancer will progress or return, previously tested in samples of breast cancer survivor caregivers/spouses, Cronbach alpha=.91.

  Day 1

Secondary Outcomes (1)

• PROMIS Depression Short Form (8 items)

  Day 1

Study Arms (1)

Partners of breast cancer survivors

Convenience sample of partners/significant others/spouses of breast cancer survivors

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Potential participants will be identified through multiple venues: Facebook, RED Alliance, community organizations in Indianapolis and surrounding areas, inResearch.org, Army of Love, ResNet (the latter three are research participant registries).

You may qualify if:

• Identifies as a partner, significant other, or spouse of an individual diagnosed with non-metastatic breast cancer
• Is 18 years of age or over
• Is able and willing to attend a focus group, individual interview, or complete an online survey
• Is able to access the internet
• Is able to carry on normal everyday conversation

You may not qualify if:

• · Partners who have separated or divorced since survivors' diagnosis

Sponsors & Collaborators

• Indiana University: lead
• Indiana Clinical and Translational Sciences Institute: collaborator

Study Sites (1)

Andrea A Cohee

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: July 2, 2021
• First Posted: February 8, 2022
• Study Start: September 1, 2019
• Primary Completion: March 1, 2022
• Study Completion: March 1, 2022
• Last Updated: March 7, 2023

Record last verified: 2023-03

Locations

US (1)